Academic literature on the topic 'Urgence nocturne'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Urgence nocturne.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Urgence nocturne":
1
Jaya Amal, Rizki. "THE IMPACT OF NOCTURIA ON MORTALITY : A SYSTEMATIC REVIEW." Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425) 9, no. 4 (April 17, 2023): 17–21. http://dx.doi.org/10.53555/nnmhs.v9i4.1644.
Abstract:
The International Classification of Sleep Disorders (ICS) describes nocturia as "voiding that occurs during the main sleep period". However, there are some medical specialists who do not believe that feeling one emptiness while sleeping qualifies as a clinically important occurrence. They believe that this viewpoint is supported by the evidence. This might be owing to the fact that some studies have indicated that having fewer than two voids every night is not an issue, whilst other studies have found that having more than two voids every night can reduce quality of life. Having fewer than two voids every night is not a problem. Having more than two voids every night is a problem. The most common and bothersome symptom related to urination is called nocturia. 10 million people in the United States suffer with nocturia, yet only 1.5 million get treated for it. This annoys seventy percent of individuals over the age of thirty who get up at least twice throughout the night to use the toilet. People who suffer from the illness known as nocturnal enuresis are characterized by their inability to recognize when they have a full bladder and their involuntary need to empty while sleeping. Nocturia is quite similar to nocturnal frequency, with the exception that sleep comes before and after episodes of urination. Even though voiding diaries call it nocturia, getting up in the middle of the night for any reason other than to urinate is not considered to be nocturia. Convenience void. Nocturia is frequently caused by overactive bladders rather than illnesses of the urinary system. Patients who experienced urine urgency in the afternoon were also likely to have nocturia. Mortality is increased in patients with nocturia who have three or more nocturnal voids per night. The condition known as nocturia has been linked to an increased risk of death. Those who have had nocturia more than three times are at an increased risk of mortality.
2
Akashi, Shunji, and Kazue Tomita. "The impact of a history of childhood nocturnal enuresis on adult nocturia and urgency." Acta Paediatrica 103, no. 9 (August 1, 2014): e410-e415. http://dx.doi.org/10.1111/apa.12694.
3
Calvo Charro, María. "El derecho a un cielo oscuro. Prevención y corrección de la contaminación lumínica." Asamblea. Revista parlamentaria de la Asamblea de Madrid, no. 23 (December 1, 2010): 199–221. http://dx.doi.org/10.59991/rvam/2010/n.23/341.
Abstract:
La contaminación lumínica es el resplandor producido por la luz artificial que se escapa hacia el cielo, procedente principalmente del alumbrado ineficiente, produciendo, entre otros perjuicios, aumento del gasto energético y económico, inseguridad vial, dificultades para el tráfico aéreo y marítimo, daño a los ecosistemas nocturnos y perjuicios para la salud. Es urgente proteger el cielo nocturno de la intrusión de la luz artificial, atendiendo a los beneficios que reporta para la ciencia, la cultura, la educación, el medio ambiente, la salud y la gestión responsable de los recursos energéticos. Asimismo es preciso reconocer el derecho a un cielo nocturno no contaminado que permita disfrutar de la contemplación del firmamento, como un derecho inalienable de la Humanidad, equiparable al resto de los derechos ambientales, sociales y culturales, atendiendo a su incidencia en el desarrollo de todos los pueblos y a su repercusión en la conservación de la diversidad biológica. La normativa estatal, autonómica y local, así como de las medidas administrativas capaces de incidir en la prevención y corrección de la contaminación lumínica siguen siendo hasta el momento insuficientes.
4
Fujimura, T., H. Kume, T. Sugihara, Y. Yamada, M. Suzuki, H. Nishimatsu, H. Fukuhara, T. Nakagawa, Y. Igawa, and Y. Homma. "589 Nocturia is a chaotic condition caused by nocturnal polyuria, age, comorbidity, insomnia, urgency, and bladder capacity." European Urology Supplements 13, no. 1 (April 2014): e589-e589a. http://dx.doi.org/10.1016/s1569-9056(14)60579-0.
5
Berger, Philippe. "Transfusions nocturnes de CGR sans urgence ou en urgence relative au CH de Châlons-en-Champagne : prescriptions tardives ?" Transfusion Clinique et Biologique 25, no. 4 (November 2018): 341. http://dx.doi.org/10.1016/j.tracli.2018.08.045.
6
Aoki*, Yoshitaka, Chieko Matsumoto, Masato Fukushima, Hideaki Ito, and Osamu Yokoyama. "MP31-15 NOCTURIA WITH OR WITHOUT URGENCY." Journal of Urology 203 (April 2020): e480-e481. http://dx.doi.org/10.1097/ju.0000000000000875.015.
7
Tikkinen, K. A. O., A. Auvinen, A. Tiitinen, A. Valpas, T. Keränen, A. M. Rissanen, H. Huhtala, and T. L. J. Tammela. "724 REPRODUCTIVE FACTORS ASSOCIATED WITH NOCTURIA AND URGENCY." European Urology Supplements 6, no. 2 (March 2007): 203. http://dx.doi.org/10.1016/s1569-9056(07)60719-2.
8
Mirzayeva, Nurlana, Susanne Forst, Daniel Passweg, Verena Geissbühler, Ana Paula Simões-Wüst, and Cornelia Betschart. "Bryophyllum pinnatum and Improvement of Nocturia and Sleep Quality in Women: A Multicentre, Nonrandomised Prospective Trial." Evidence-Based Complementary and Alternative Medicine 2023 (February 7, 2023): 1–8. http://dx.doi.org/10.1155/2023/2115335.
Abstract:
Nocturia is a pathologic condition that significantly affects the quality of sleep. The aetiology of nocturia is multifactorial, and the evidence available on its management remains limited. Besides behavioural measures, validated pharmaceutical treatment options exist but are, however, associated with marked side effects. Prospective clinical studies with tablets prepared from the leaf press juice of the plant Bryophyllum pinnatum revealed a tendency towards reduction of micturition in patients with overactive bladder (OAB) and several improvements in sleep quality. These observations are in part supported by in vitro and in vivo data. In the present study, we investigated the effectiveness of Bryophyllum 50% chewable tablets in the treatment of nocturia and associated sleep disorders. Altogether, 49 women with idiopathic OAB and nocturia of ≥2 voids/night were treated with Bryophyllum 50% tablets for 3 weeks (350 mg chewable tablets, dosage 0-0-2-2 oral tablets; WELEDA AG, Arlesheim, Switzerland). Nocturia, voiding volumes at night (ml), quality of life, sleep quality, and daily sleepiness were assessed before and after treatment with a 3-day micturition diary, the International Consultation on Incontinence evaluating overactive bladder and related impact on quality of life (QoL) [ICIQ-OAB], the Pittsburgh Sleep Quality Index (PSQI), and the Epworth Sleepiness Scale (ESS), respectively. The age of the study population was 68.5 ± 11.6 y. After treatment, nocturia diminished from 3.2 ± 1.4 to 2.3 ± 1.3 ( P < 0.001 ) and the PSQI score decreased from 7.7 ± 3.7 to 6.6 ± 3.4 ( P = 0.004 ). Urgency, the ICIQ score, and the ESS lowered significantly, and the micturition volume showed a tendency to increase. No serious adverse drug reactions were reported, and compliance was good. The results show a beneficial effect on the nocturnal voids and sleep quality of women with OAB. Bryophyllum 50% tablets can be regarded as a well-tolerated alternative in the treatment of nocturia and broaden the repertoire of standard management.
9
Garg, Ish. "A Case Study on Role of Kanchnaar Guggulu and Chandraprabhavati in the Management of Vatashtheela (BPH)." International Research Journal of Ayurveda & Yoga 05, no. 07 (2022): 112–17. http://dx.doi.org/10.47223/irjay.2022.5713.
Abstract:
BenignProstaticHyperplasia(BPH)isaburningsenileproblemofelderlymen,associatedwithlowerurinarytractsymptoms(LUTS).Theprevalencefiguresvaryfromabout10-30%formenbetween50-60yearsofageto25-45%intheagegroupof70-80years.BPHisaprogressivediseasethatispresentedascommonsymptomssuchasfrequenturination,urgency,nocturia,decreasedandintermittentforceofstream,andthesensationofincompletebladderemptying.InAyurveda,VatashtheeladiseasecloselyresembleswithBenignProstaticHyperplasiaofmodernmedicineinitssignsandsymptoms.ItismanifestedduetoimproperfunctionofApanaVaatalongwiththevitiationofKaphaandPittaDoshas.Inthiscasestudy,thepatientwasadministeredChandraprabhaVati&KanchnaarGuggulu,atadoseof1tabtwiceadayand2tabtwiceadayrespectivelyfortwomonths.TheirritativeandobstructivesymptomsofBPH(Vatashtheela)likefrequency,urgency,staining,weakstream,incompleteemptying,nocturia,residualurineandsize&weightofprostatewereobservedoverthetreatment.AnalysisofresultshowedimprovementinVatashtheela(BPH).FinallystudyconcludedthatgiventreatmentisfoundeffectiveinmanagementofVatashtheela(BPH)
10
Okumura, Y., M. Fukushima, Y. Aoki, H. Ito, and O. Yokoyama. "Which affects nocturnal frequency most: Urgency or sleep disorders?" European Urology 81 (February 2022): S1242—S1243. http://dx.doi.org/10.1016/s0302-2838(22)00917-4.
Dissertations / Theses on the topic "Urgence nocturne":
1
El, Ansari Loridan Nazha. "Décider en situation d’urgence nocturne en EHPAD (Etablissement d'Hébergement pour Personnes Agées Dépendantes) : Étude d’une innovation expérimentale d’infirmier.es de nuit." Electronic Thesis or Diss., Université de Lille (2022-....), 2023. http://www.theses.fr/2023ULILA024.
Abstract:
Cette thèse étudie comment des infirmier.es de nuit prennent la décision de recourir ou non à l'hôpital en cas d'urgence gériatrique en EHPAD. Le raisonnement clinique et la prise de décision chez des infirmiers sont rarement documentés. L'expérimentation « IDE de nuit » des projets paerpa offrait l'occasion de les étudier au prisme de l'âge et de l'incertitude dans un contexte d'urgence. Elle a aussi permis d'étudier l'épreuve organisationnelle que constitue une telle innovation. En mobilisant une approche interactionniste et sociocognitive et en nous fondant sur une enquête ethnographique trois années durant, nous avons saisi in situ le raisonnement et le jugement infirmiers à l'épreuve de l'urgence et du contexte expérimental. Cette recherche éclaire plusieurs aspects : comment le care est mobilisé au service du cure ; comment l'urgence constitue une construction, qui est influencée par le rôle joué par le patient âgé et ses aides-soignantes ; comment les compétences qui font l'innovation s'élaborent à l'épreuve de l'irréversibilité des actions et des résultats ; comment et quand commence et se termine une innovation organisationnelle dans un contexte expérimental ; enfin, comment tous ces éléments participent à définir l'économie morale qui s'est mise en place autour des personnes âgées vivant en EHPAD, cibles de cette innovation.Mot clés : urgence gériatrique, prise de décision, innovation organisationnelle, IDE de nuit, expérimentation, paerpa, le 15, recours à l'hôpital, aides-soignantes, EHPADThis thesis studies how night-shift nurses decide whether or not to resort to the hospital to deal with geriatric emergency cases in a nursing home. Clinical reasoning and decision-making among nurses are rarely documented. The “IDE de nuit” experimentation of Paerpa's projects offered the opportunity to study them through the prism of age and uncertainty in the context of an emergency. It also made it possible to study the organizational test that such an innovation constitutes. Through an interactionist and socio-cognitive approach and based on an ethnographic investigation lasting three years, we captured in situ nurses' reasoning and judgment while dealing with emergency cases in an experimental context. This research sheds light on several aspects: how care is mobilized in the service of the cure; how the emergency constitutes a social construction, which is influenced by the role played by the elderly patient and his caregivers; how the skills that drive innovation are developed and conditioned by the irreversibility of the actions and their results; how and when an organizational innovation begins and ends in an experimental context; finally, how all these elements contribute to defining the moral economy that has been made up and created around elderly people living in EHPADs, targets of this innovation.Keywords: geriatric emergency, decision-making, organizational innovation, IDE de nuit, experimentation, paerpa, le 15, SAMU, hospital, nursing assistants, EHPAD
2
Schoendorfer, Niikee, Nita Sharp, Tracey Seipel, Alexander G. Schauss, and Kiran D. K. Ahuja. "Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root, in the treatment of symptoms of overactive bladder and urinary incontinence: a phase 2, randomised, double-blind placebo controlled trial." BIOMED CENTRAL LTD, 2018. http://hdl.handle.net/10150/627047.
Abstract:
Background: Storage lower urinary tract symptoms (LUTS) including overactive bladder (OAB) and urinary incontinence (UI) affect millions of people worldwide, significantly impacting quality of life. Plant based medicines have been documented both empirically and in emerging scientific research to have varying benefits in reducing bladder symptoms. We assessed the efficacy of Urox (R), a proprietary combination of phytomedicine extracts including, Cratevox (TM) (Crataeva nurvala) stem bark, Equisetem arvense stem and Lindera aggregata root, in reducing symptoms of OAB and UI. Methods: Efficacy of the herbal combination on a variety of bladder symptoms compared to an identical placebo, were documented in a randomised, double-blind, placebo controlled trial conducted at two primary care centres. Data were collected at baseline, 2, 4 and 8 weeks, with the primary outcome being self-reported urinary frequency. Statistical analysis included mixed effects ordered logistic regression with post hoc Holm's test to account for repeated measures, and included an intention-to-treat analysis. Results: One hundred and fifty participants (59% female, aged; mean +/- SD; 63.5 +/- 13.1 years) took part in the study. At week 8, urinary day frequency was significantly lower (OR 0.01; 95%CI 0.01 to 0.02; p < 0.001) in response to treatment (mean +/- SD; 7.69 +/- 2.15/day) compared to placebo (10.95 +/- 2.47/day). Similarly, episodes of nocturia were significantly fewer (OR 0.03; 95%CI 0.02 to 0.05) after 8 weeks of treatment (2.16 +/- 1.49/night) versus placebo (3.14 +/- 1.36/night). Symptoms of urgency (OR 0.02; 95%CI 0.01 to 0.03), and total incontinence (OR 0.03; 95%CI 0.01 to 0.06) were also lower (all p < 0.01) in the treatment group. Significant improvements in quality of life were reported after treatment in comparison to placebo. No significant side effects were observed resulting in withdrawal from treatment. Conclusions: The outcome of this study demonstrated both statistical significance and clinical relevance in reducing symptoms of OAB, urinary frequency and/or urgency and incontinence. The demonstrated viability of the herbal combination to serve as an effective treatment, with minimal side-effects, warrants further longer term research and consideration by clinicians.
3
Swithinbank, Lucy. "Urinary symptoms and incontinence in women : relationships between occurrence, age prevalence, perceived bother and quality of life." Thesis, University of Bristol, 2000. http://hdl.handle.net/1983/496876df-ad70-4d22-8250-0c3016157d8d.
4
Araújo, Tatiane Gomes de. "Tratamento da síndrome da bexiga hiperativa neurogênica feminina na doença de Parkinson através da estimulação transcutânea do nervo tibial posterior." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2017. http://hdl.handle.net/10183/169570.
Abstract:
Base teórica: Disfunções do trato urinário inferior são sintomas não motores comuns na Doença de Parkinson (DP) e incluem a Síndrome da Bexiga Hiperativa Neurogênica (SBHN), caracterizada pela urgência miccional, com ou sem urgeincontinência, acompanhada de aumento da frequência urinária e noctúria. A estimulação do nervo tibial posterior (ENTP) é uma das modalidades de tratamento disponíveis para o tratamento da SBHN. Objetivo: Determinar e comparar os efeitos do tratamento com ENTP em pacientes com DP e sintomas de SBHN e a manutenção dos resultados em 1 e 3 meses após o término do tratamento. Métodos: Ensaio-clínico, duplo-cego, randomizado, controlado e comparado com placebo. A pesquisa foi realizada com mulheres com DP e sintomas de SBHN no Hospital de Clínicas de Porto Alegre. Para o tratamento com ENTP domiciliar por 12 semanas as pacientes foram divididas em dois grupos: grupo ENTP e grupo ENTP sham/placebo. A avaliação da resposta pré e pós-tratamento foi realizada através de formulário específico, questionários de avaliação da incontinência urinária e qualidade de vida (OAB-V8 e KHQ) e de um diário miccional (DM) de 24 horas. Após, o fim do tratamento foi feito seguimento dos resultados para avaliação da melhora subjetiva em 30 e 90 dias. Resultados: O grupo ENTP apresentou uma diminuição da noctúria, número de episódios de urgência micciional e urge-incontinência, número de uso de proteções para incontinência, pontuação OAB-V8 e em sete domínios do KHQ (p <0,001). Embora, o grupo controle também tenha apresentado melhora dos sintomas, o grupo ENTP apresentou uma melhora superior no final do tratamento nas medidas do DM, OAB-V8 e na maioria dos domínios do KHQ. A ETNTP foi considerada um tratamento efetivo para SBHN em 93,3%, enquanto 33,3% dos tratados com placebo também melhoraram (p = 0,002). No seguimento de 30 e 90 dias, 53,3% e 33,31%, respectivamente, do grupo ENTP relataram que mantinham- se melhores dos sintomas da SBHN. Conclusão: a ENTP foi um tratamento efetivo para as pacientes com DP e SBHN. Nossa hipótese de superioridade clínica do grupo ENTP foi confirmada e a melhora subjetiva foi considerada positiva, mesmo que parcialmente em 30 e 90 dias após fim do tratamento.Blackround: Lower urinary tract dysfunctions are common non-motor symptoms in Parkinson's disease (PD) and include Neurogenic Overactive Bladder Syndrome (NOBS), characterized by urinary urgency, with or without urge incontinence, accompanied by increased urinary frequency and nocturia . Posterior Tibial Nerve Stimulation (PTNS) is one of the treatment modalities available for the treatment of NOBS. Objective: To determine and compare the effects of PTNS treatment in patients with PD and NOBS symptoms and to maintain long-term results (1 and 3 months). Methods: Controlled, randomized, double-blind and compared with placebo clinical trial. The research was carried out with women with PD and symptoms of NOBS at the Hospital de Clínicas de Porto Alegre. For treatment with PTNS at 12 weeks, patients were divided into two groups: PTNS group and PTNS sham/placebo group. The evaluation of the pre- and post-treatment response was through a specific form, questionnaires to evaluate incontinence and quality of life (OVA-V8 and KHQ), and a voiding diary. After the end of the treatment, the results were followed up to evaluate the subjective improvement in 30 and 90 days. Results: The PTNS group presented a decreased nighttime urinary frequency, number of urgency and urinary incontinence episodes, number of incontinence protection, OAB-V8 and 7 domains of KHQ (p<0.001). Although the control group also showed improvement of the symptoms, the ENTP group presented a superior improvement at the end of the treatment in DM, OAB-V8 and most KHQ domains. PTNS was considered an effective treatment for OAB in 93.3%, while 33.3% of those treated with placebo was considered a responder (p=0.002). After 30 and 90 days, 53.3% and 33.31%, respectively, of the ENTP group reported that they maintained better SBHN symptoms. Conclusion: PTNS was an effective treatment for patients with PD and NOBS. Our hypothesis of clinical superiority of the ENTP group was confirmed and the subjective improvement was considered positive, even if partially at 30 and 90 days after the end of the treatment.!
Books on the topic "Urgence nocturne":
1
Jackson, Simon, and Natalia Price. Urinary incontinence. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0059.
Abstract:
Urinary incontinence is the complaint of any involuntary leakage of urine. Stress urinary incontinence is involuntary leakage of urine on effort. exertion, sneezing, or coughing. Urge urinary incontinence is involuntary leakage of urine accompanied by, or immediately preceded by, a strong desire to pass urine (void). Urgency with or without urge urinary incontinence and usually with frequency and nocturia is also termed overactive bladder syndrome. Mixed urinary incontinence is involuntary leakage of urine associated with both urgency and exertion, effort, sneezing, or coughing. Usually, one of these is predominant; that is, either the symptoms of urge incontinence or those of stress incontinence are most bothersome. Overflow incontinence occurs when the bladder becomes large and flaccid and has little or no detrusor tone or function. It is usually due to injury or insult, occurring post surgery or post-partum. The bladder simply leaks when it becomes full. Incontinence due to a fistula is incontinence resulting from a vesicovaginal, ureterovaginal, or urethrovaginal fistula. Congenital incontinence is incontinence due to congenital causes (e.g. an ectopic ureter).
Book chapters on the topic "Urgence nocturne":
1
Beckman, Thomas J. "Men’s Health." In Mayo Clinic Internal Medicine Board Review, 337–44. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190464868.003.0030.
Abstract:
Benign prostatic hyperplasia (BPH) is common among older men. The prostate is the size of a walnut (20 cm3) in men younger than 30 years and gradually increases in size, leading to BPH in most men older than 60 years. BPH results from epithelial and stromal cell growth in the prostate, which in turn causes urinary outflow resistance. Over time, this resistance leads to detrusor muscle dysfunction, urinary retention, and lower urinary tract symptoms, such as urgency, frequency, and nocturia.
2
Collins, Nerissa M. "Otolaryngology and Ophthalmology." In Mayo Clinic Internal Medicine Board Review, 345–48. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190464868.003.0031.
Abstract:
Benign prostatic hyperplasia (BPH) is common among older men. The prostate is the size of a walnut (20 cm3) in men younger than 30 years and gradually increases in size, leading to BPH in most men older than 60 years. BPH results from epithelial and stromal cell growth in the prostate, which in turn causes urinary outflow resistance. Over time, this resistance leads to detrusor muscle dysfunction, urinary retention, and lower urinary tract symptoms, such as urgency, frequency, and nocturia.
3
Beckman, Thomas J. "Men’s Health." In Mayo Clinic Internal Medicine Board Review, edited by Christopher M. Wittich, Thomas J. Beckman, Sara L. Bonnes, Nina M. Schwenk, Jason H. Szostek, Nerissa M. Collins, and Christopher R. Stephenson, 353–60. 12th ed. Oxford University PressNew York, 2019. http://dx.doi.org/10.1093/med/9780190938369.003.0031.
Abstract:
Abstract Benign prostatic hyperplasia (BPH) is common among older men and results from epithelial and stromal cell growth in the prostate, which in turn causes urinary outflow resistance. Over time, this resistance leads to detrusor muscle dysfunction, urinary retention, and lower urinary tract symptoms (LUTS), such as urgency, frequency, and nocturia. Evidence has shown that BPH progresses when left untreated. Complications of BPH include urinary tract infections, obstructive nephropathy, and recurrent hematuria. Male sexual dysfunction includes ED, decreased sexual desire (libido), anatomical abnormalities (eg, Peyronie disease), and ejaculatory dysfunction and affects millions of men in the United States.
4
Barry, Michael J. "Decision support in the treatment of prostate conditions." In Shared Decision-Making in Health Care, 317–24. Oxford University PressOxford, 2009. http://dx.doi.org/10.1093/oso/9780199546275.003.0044.
Abstract:
Abstract BPH is common among older men worldwide. For unclear reasons, as men age, the tissues of the prostate gland expand and coalesce, eventually causing prostate enlargement, bladder outlet obstruction, and secondary detrusor (bladder muscle) instability. The morbidity of BPH is largely due to its associated lower urinary tract symptoms (LUTS), including urgency, frequency, nocturia, incomplete emptying, straining, intermittency, and a weak stream. Men with BPH may also develop acute urinary retention, the inability to urinate at all; urinary tract infections; and rarely, renal insufficiency (Barry, 2006). Not all LUTS are attributable to BPH; and conversely, many men with BPH never develop bothersome symptoms.
5
van Nes, Jaclyn. "A 30-Year-Old Woman with Frequency, Urgency, Nocturia, and Pressure Relieved by Urination." In Office Gynecology, 266–68. Cambridge University Press, 2019. http://dx.doi.org/10.1017/9781108227469.085.
6
Farne, Hugo, Edward Norris-Cervetto, and James Warbrick-Smith. "Polyuria." In Oxford Cases in Medicine and Surgery. Oxford University Press, 2015. http://dx.doi.org/10.1093/oso/9780198716228.003.0029.
Abstract:
In both polyuria and high urinary frequency the patient will be passing urine more often than before. But in polyuria, patients will pass abnormally large volumes of clear urine each time. In urinary frequency, the volume voided each time will be normal or reduced. The only way of knowing objectively whether this is the case is by collecting a 24-hour urine sample (>3 L = polyuria). As this is usually impractical outside of hospital, one must rely on the patient’s recall, with the caveat that many patients find it difficult to estimate urine output. In the history, then, ask them whether they feel they are passing a larger volume every time they go to the toilet. Remember that it is important to be as sure as you can that you are dealing with polyuria and not urinary frequency or nocturia, as the differential diagnoses are quite distinct. Chronic renal failure and hypercalcaemia (e.g. due to bone metastases) cause polyuria by inducing nephrogenic diabetes insipidus. Similarly, steroids and Cushing’s syndrome can cause polyuria by causing diabetes mellitus. • Temporal pattern of urine output (number of times in the day and at night), especially nocturia. At night, the kidneys concentrate urine in order to retain fluid (as intake is zero), removing the need to urinate during sleep. Thus nocturia (in the absence of other causes of nocturia, e.g. benign prostatic hyperplasia (BPH)) is often one of the earliest signs of a loss of concentrating ability. This symptom makes primary polydipsia less likely. • Fatigue, weight loss, recurrent infections. All can be features of diabetes mellitus. • Lower urinary tract symptoms (LUTS), e.g. frequency, urgency, hesitancy, terminal dribbling, incomplete voiding. These symptoms indicate pathology in the bladder or the outflow tract, e.g. prostatism in men, detrusor instability and prolapse in women. Not strictly speaking polyuria. • Pain, frequency, change in urine colour and smell. These are all symptoms suggestive of a urinary tract infection (UTI), which would cause increased frequency but not polyuria. • Past medical history. Look for any history of renal problems or conditions that may precipitate chronic renal failure (e.g. vasculitides, hypertension, chronic urinary retention).
7
Ullah, Asad, and Muhammad Jamil. "Interstitial Cystitis/Bladder Pain Syndrome." In Cystitis - Updates and Challenges [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.111676.
Abstract:
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a heterogeneous, chronic, and debilitating condition. It affects 400,000 individuals in the United Kingdom. IC/BPS presents with suprapubic pain or discomfort perceived to be related to the urinary bladder with one or more urinary symptoms (e.g., urgency, frequency or nocturia) for more than 6 weeks. The exact etiology is not clearly understood. It can sometimes co-exist with other chronic pain disorders, complicating the diagnosis and management. IC/BPS can adversely impact the quality of life, impede work, and interfere with the sleep, sexual and social life of the affected individual. The contemporary treatments are palliative and aim for symptom control only. There is no cure available presently. Moreover, treatment effects are highly variable; therefore, personalization of treatment is vital for achieving the desired outcomes. Management includes lifestyle modifications, physical therapy, systemic pharmacotherapy, intravesical therapies and surgery. Conservative treatments are usually used first, followed by invasive and combination therapies if required. Treatment should aim beyond symptom improvement and encompass improvement in quality of life. Further research is needed to understand the etiology and pathophysiology of IC/BPS. It will assist in the development of new biomarkers and drug development.
8
Roy Moulik, Sujata, and Rupali Nayek. "Light Pollution in Urban Life: Effects on Environment and Human Health." In A Basic Overview of Environment and Sustainable Development [Volume 2], 563–75. 2nd ed. International Academic Publishing House (IAPH), 2023. http://dx.doi.org/10.52756/boesd.2023.e02.034.
Abstract:
Artificial lighting is indispensable for human activity. One thing that is not emphasized is the fact that it is the one that is responsible for the creation of light pollution. On the other hand, a significant amount of energy is wasted, and this pollution is clearly visible and thus, it has a disruptive effect on the nocturnal sky. Since numerous of these disastrous effects may be experienced, among these well-known are the death of birds flying over buildings illuminated by lights and the disorientation of hatchling sea turtles on natal beaches, the latter caused by light pollution. Little is understood about the severe consequences of these brightening levels on species behavior and even community ecology. Along with being to address the conservation issues, this is a novice area of ecology research. However, all of the risk factors are time-urgent and thus, there are feasible solutions to each of those risks.
9
D. Zivkovic, Vesna, Ivona Stankovic, Lidija Dimitrijevic, Hristina Colovic, Dragan Zlatanovic, and Natasa Savic. "Rehabilitation Protocols for Children with Dysfunctional Voiding." In Pelvic Floor Disorders [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.98573.
Abstract:
Dysfunctional voiding is a functional voiding disorder characterized by an intermittent uroflow rate due to involuntary intermittent contractions of the striated muscle of the external urethral sphincter or pelvic floor muscles (PFMs) during voiding in neurologically normal children. Symptoms include voiding difficulties as well as urgency, voiding frequency and, in some instances, urinary incontinence and/or nocturnal enuresis. Recurrent urinary tract infections, chronic constipation and/or fecal incontinence and vesicoureteral reflux (VUR) contribute to this condition. Urotherapy is the mainstay of the treatment. It starts with education and demystification and simple behavioral modifications. Specific measures include PFM exercises with various forms of biofeedback concentrating at the recognition of PFM function and their relaxation. However, the PFMs are part of the abdominal capsule and they act in coordination with lower abdominal muscles. These muscles need to be relaxed during voiding. Diaphragmatic breathing exercises were introduced to teach children abdominal muscle relaxation. Easy to learn exercises do not require any specific equipment and can be performed at all health care levels. Children from five years of age could benefit from these exercises. In children resistant to standard treatment, botulinum toxin type A application, intermittent catheterization and surgery in children with VUR are recommended.
10
Ahlskog, J. Eric. "Hospitalization and Nursing Facilities: Keeping Everyone on the Same Page." In Dementia with Lewy Body and Parkinson's Disease Patients. Oxford University Press, 2013. http://dx.doi.org/10.1093/oso/9780199977567.003.0032.
Abstract:
Nearly all of us end up in the hospital for something sooner or later. The unique problems of Lewy disorders and medications can challenge hospital care teams. On a related note, some individuals with DLB or PDD may require care in a nursing facility. This may be transient, requiring rehabilitation and stabilization following a hospitalization; in other cases, it is indefinite because of the complex care necessary for DLB and PDD. In this chapter, the focus is on the care teams in these facilities. Although many staff in these settings are familiar with the medications and problems of DLB and PDD, this knowledge is not universal. Little published literature addresses the special needs of those with PDD or DLB admitted to the hospital or living in extended care facilities. It is hoped that this chapter can be an aid in caring for those with PDD or DLB. People with DLB or PDD are, by definition, cognitively impaired. Sometimes this is associated with hallucinations or delusions. Most individuals also have dopamine deficiency states with parkinsonism. Another common component is autonomic nervous system dysfunction. This dysautonomia may be associated with bladder and bowel disorders but, more importantly, with orthostatic hypotension (potential for fainting when ambulating). Some people with PDD or DLB are mildly impaired by these problems, and others are quite compromised. What follows is a summary of crucial knowledge for nursing and paramedical staffs. 1. As with any dementia, novel environments are disorienting. 2. Hallucinations are a frequent component of DLB and PDD. These may be exacerbated by psychoactive medications, including narcotics for pain. 3. Carbidopa/levodopa is the least likely among the potent drugs for parkinsonism to provoke hallucinations. Other Parkinson drugs should generally not be started. 4. People with DLB or PDD commonly experience dream enactment behavior (REM sleep behavior disorder); this should not be misinterpreted as nocturnal hallucinations. 5. Anticholinergic medications for urinary urgency may cross the blood–brain barrier and impair cognition (e.g., oxybutynin). The only drug from this class that cannot get into the brain is trospium (Sanctura).
Conference papers on the topic "Urgence nocturne":
1
Speich, John E., Anna S. Nagle, Stefan G. De Wachter, and Adam P. Klausner. "The Sensation Meter: An Unprompted Method to Characterize Patient-Reported Bladder Sensation in Real-Time." In 2017 Design of Medical Devices Conference. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/dmd2017-3433.
Abstract:
Overactive bladder (OAB) syndrome is characterized by symptoms of urgency, with or without incontinence, usually with increased voiding frequency and nocturia [1], and is prevalent throughout the world [2]. Chronic OAB symptoms are studied with validated surveys, while acute symptoms can be assessed using bladder diaries. These methods may be subject to recall bias, since diaries are typically completed after voiding. The accepted standard for clinical assessment of bladder function and sensation is a urodynamics (UD) study which involves filling the bladder with a catheter. During a UD study, three verbal sensory thresholds (VSTs) are recorded [3]. These thresholds, First Sensation, First Desire to void, and Strong Desire to void, only provide limited, episodic information about acute sensation during filling. Thus, there is a clear need for a tool to evaluate the development of real-time bladder sensation during bladder filling. The objective of this study was to develop a novel Sensation Meter, a patient interface implemented on a touchscreen device that continuously records the patient’s real-time, unprompted sensation of bladder fullness.